CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 8-K Event Results of operations
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Shares withheld for taxes Chief Financial Officer gave up 136,745 shares (to pay taxes)
- 4 Shares withheld for taxes CEO & President, ImprimisRx gave up 109,475 shares (to pay taxes)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Shares withheld for taxes Chief Executive Officer gave up 300,363 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 5,000 shares at $30.01 ($150,055)
- 4 Open-market sale 10% owner sold 5,000 shares at $29.64 ($148,200)
- NT 10-K Other NT 10-K
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 5,000 shares at $28.05 ($140,250)
- 4 Open-market sale 10% owner sold 20,000 shares at $35.59 ($711,814)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
Page 5 of 44 · 872 filings